Non-diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) not diagnosed with diabetes (2) be at least 20 years of age at the time of informed consent (3) have been fully informed of the purpose of participation in this study, and have given written consent of their own free will based on a thorough understanding of the purpose of the study
Exclusion criteria
Exclusion criteria: (1) The individuals who are taking drugs that affect glucose metabolism (steroids, immunosuppressants, beta-blockers) (2) pregnant or possibly pregnant (3) The individuals who are breast-feeding (4) The individuals have a known history of hypersensitivity to the test drug or the ingredients in the test (5) The individuals who have received a cardiac function classification of 3 or 4 by NYHA within the last 1 year (6) The individuals who have been diagnosed with severe renal dysfunction (eGFR 30 mL/min/1.73 m2 or less) within the last 1 year (7) Persons with blood clotting abnormalities (8) The individuals who have been diagnosed with thyroid function abnormalities or electrolyte within the last 1 year (9) In addition, when the principal investigator deems the patient to be inappropriate as a subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Examination of fitting of a novel mathematical model incorporating glucose effectiveness | — |
Secondary
| Measure | Time frame |
|---|---|
| Relevance of insulin action on elevated blood glucose | — |
Countries
Japan
Contacts
Kobe university Department of Diabetes and Endocrinology